Pison Technology, a leading AI company, has developed a revolutionary tool that can detect the presence of neurological disorders in patients with Amyotrophic Lateral Sclerosis (ALS). According to a recent landmark study, the AI technology developed by Pison was able to identify 70% of ALS patients with a 95% accuracy rate.

ALS, also known as Lou Gehrig’s disease, is a rare and incurable neurological disorder that affects nerve cells responsible for controlling voluntary muscles. This groundbreaking technology developed by Pison could enable early detection of ALS, leading to earlier treatment and potentially improving the quality of life for ALS patients.

The study involved analyzing data from over 800 patients, making it one of the largest studies of its kind in ALS research. Pison’s AI technology uses machine learning algorithms to analyze patterns in brain scans and identify neurological changes associated with ALS. The company plans to continue researching and developing this technology to improve its accuracy and effectiveness in detecting neurological disorders.

Read more: https://www.businesswire.com/news/home/20230418005133/en/Landmark-Study-Finds-Pison-AI-Technology-Can-Detect-Neurological-Disorder-in-ALS-Patients